Home / Inspections / 1309538

FDA Inspection 1309538 — Orion Corporation, Orion Pharma

Orion Corporation, Orion Pharma — FEI 3003743938

The FDA completed an inspection of Orion Corporation, Orion Pharma on April 25, 2024 in Turku. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
April 25, 2024
Fiscal Year
2024
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Turku (Finland)

Additional Details

Mutual Recognition Agreement (MRA)

Facility

Other inspections at this facility

  • 1201298 (VAI Thu Mar 10 2022 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1106590 (VAI Fri Sep 06 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 992916 (NAI Thu Nov 03 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 889323 (NAI Thu Jun 19 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 836582 (VAI Fri May 24 2013 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources